American Nurse Today – May 2008
CRRT spells success against acute renal failure in critically ill patients
Bell M, Granath F, Schon S, Ekbom A, Martling CR. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med. 2007;33:773-780. Bellomo R, Ronco C. Acute renal failure in the ICU: adequacyof dialysis and the case for continuous therapies. Nephrol Dial Transplant. 1996;11:424-428.
Clark WR, Letteri JJ, Uchino S, Bellomo R, Ronco C. Recent clinical advances in the management of critically ill patients with acute renal failure. Blood Purif. 2006;24:487-498.
Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol. 1997;8:804-812.
Clark WR, Ronco C. Continuous renal replacement techniques. Contrib Nephrol. 2004;144:264-277.
Dirkes S, Hodge K. Continuous renal replacement therapy in the adult intensive care unit. Crit Care Nurse. 2007;27:61-81.
Hoste E, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73-R83.
Kellum JA. Renal replacement therapy in critically ill patients with acute renal failure: does a greater dose improve survival? Nat Clin Pract Nephrol. 2007;3:128-129.
Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care. 2002;8:509-514.
Liao Z, Zhang W, Poh CK, et al. Kinetic comparison of different acute dialysis therapies. Artif Organs. 2003;27:802-807.
Manns B, Doig CJ, Lee H, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med. 2003;31:449-455.
Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66:1613-1621.
Ronco C. CRRT protects the kidney during acute renal failure. Int J Artif Organs. 2007;30:279-280.
Ronco C. Renal replacement therapy for acute kidney injury: let’s follow the evidence. Int J Artif Organs. 2007;30:89-94.
Salvatori G, Ricci Z, Bonello M, et al. First clinical trial for a new CRRT machine: the Prismaflex. Int J Artif Organs. 2004;27:404-409.
Sinert R. Acute renal failure. May 2006. www.emedicine.com/emerg/topic500.htm. Accessed March 19, 2008.
Uchino S, Bellomo R, Kellum JA, et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs. 2007;30:281-292.
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294.813-818.
Ympa YP, Reinhart K, Vincent JL. Has mortality from acute renal failure increased? A systematic review of the literature. Am J Med. 2005;118:827-832.
Institute of Medicine. Crossing the Quality Chasm. Washington, DC:
National Academy Press; 2001.
Institute of Medicine. To Err is Human: Building a Safer Health System.
Washington, DC; National Academy Press; 2000.
Stopping the silent progression of osteoporosis
Adachi JD, Ioannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12:903-908.
Andrews WC. What’s new in preventing and treating osteoporosis? Postgrad Med. 1998;104:89-97.
Berarducci A. Osteoporosis: Clinical Issues, Detection, and Treatment Strategies. A Continuing Education Self-Study Program for Nurses and Nurse Practitioners. 3rd ed. Glendale, AZ: American Academy of Nurse Practitioners Foundation; 2002.
Berarducci A, Haines K, Murr MM. Risk of injuries, falls and skeletal fragility following bariatric surgery for morbid obesity. Appl Nurs Res. In press.
Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab. 1999;84:3431-3434.
Bone health and osteoporosis: a report of the Surgeon General. October 14, 2004. HYPERLINK “http://www.surgeongeneral.gov/library/bonehealth” http://www.surgeongeneral.gov/library/bonehealth. Accessed March 12, 2008.
Bone HG, Hosking D, Devogelaer J-P, et al; Alendronate Phase III Osteoporosis Treatment Study Group. Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med. 2004;350:1189-1199.
Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc. 2004;52:1832-1839.
Bracker MD, Watts NB. How to get the most out of bone densitometry. Results can help assess fracture risk and guide therapy. Postgrad Med. 1998;104:77-86.
Chesnut CH III, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med. 2000;109:267-276.
Chesnut CH III, Skag A, Christiansen C, et al. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res. 2004;19:1241-1249.
Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2008.
Cosman F. The prevention and treatment of osteoporosis: a review. Journal CME. May 2005. HYPERLINK “http://www.medscape.com/viewprogram/4011” www.medscape.com/viewprogram/4011. Accessed March 12, 2008.
Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761-1767.
Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002;359:2018-2026.
Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87:3609-3617.
Delmas PD, Recker RR, Chesnut CH 3rd, et al. Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study. Osteoporos Int. 2004;15:792-798.
FDA updates health claim for calcium and osteoporosis. U.S. Food and Drug Administration. HYPERLINK “http://www.fda.gov/bbs/topics/NEWS/2007/NEW01543.html” www.fda.gov/bbs/topics/NEWS/2007/NEW01543.html. Accessed March 12, 2008.
“Fit to a T” Program for patients and community. US Bone and Joint Decade. 2004. HYPERLINK “http:// www.usbjd.org/projects/Fit2aT_op.cfm?CFID=1576904&CFTOKEN=77878264” www.usbjd.org/projects/Fit2aT_op.cfm?CFID=1576904&CFTOKEN=77878264. Accessed March 12, 2008.
Gamble CL. Osteoporosis: drug and nondrug therapies for the patient. Geriatrics. 1995;50:39-43.
Gregg EW, Pereira MA, Caspersen CJ. Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc. 2000;48:883-893.
Haentjens P, Autier P, Collins J, Velkeniers B, Vanderschueren D, Boonen S. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am. 2003;85-A(10):1936-1943.
Harris ST, Watts NB, Li Z, et al. Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. Curr Med Res Opin. 2004;20:757-764.
Health Resources and Service Administration. The Registered Nurse Population: Findings from the March 2004 National Sample Survey of Registered Nurses. Washington, DC: U.S. Department of Health and Human Services; 2007.
International Osteoporosis Foundation. HYPERLINK “http://www.iofbonehealth.org” www.iofbonehealth.org. Accessed March 12, 2008.
International Society for Clinical Densitometry. Official positions. HYPERLINK “http://iscd.org/Visitors/positions/OfficialPositionsText.cfm” http://iscd.org/Visitors/positions/OfficialPositionsText.cfm. Accessed March 12, 2008.
McClung MR, Wasnich RD, Recker R, et al. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res. 2004;19:11-18.
Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002;17:2222-2230.
Morrissey M. Exercise and mental health: a qualitative study. Ment Health Nurs. 1997;17:6-8.
National Osteoporosis Foundation. HYPERLINK “http://www.nof.org” www.nof.org. Accessed March 12, 2008.
Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294-1301.
Orwoll ES, Klein R. Osteoporosis in men. Epidemiology, pathophysiology, and clinical characterization. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. 2nd ed. San Diego, CA: Academic Press; 2001:103-149.
Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko N. Diagnosis and management of vertebral fractures in elderly adults. Am J Med. 2002;113:220-228.
Richards JB, Papaioannou A, Adachi JD, et al; Canadian Multicentre Osteoporosis Study (CaMos) Research Group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188-194.
Rosen CJ, Rackoff PJ. Emerging anabolic treatments for osteoporosis. Rheum Dis Clin North Am. 2001;27:215-233, viii.
Rossouw JE, Anderson GL, Kooperber C, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
Rozenberg S, Vandromme J, Kroll M, Twagirayezu P, Vyankandondera J, Claus K. The brittle bone: how to save women from osteoporosis. Int J Fertil Womens Med. 1997;42(2):101-106.
Schussheim DH, Siris ES. Osteoporosis: update on prevention and treatment. Women’s Health in Primary Care. 1998;1:133-136, 139-140.
Seeman E. Trials and tribulations. Am J Med. 1997;103:74S-89S.
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-2822.
Sowers M. Clinical epidemiology and osteoporosis. Measures and their interpretation. Endocrinol Metab Clin North Am. 1997;26:219-231.
Vondracek SF, Hansen LB. Current approaches to the management of osteoporosis in men. Am J Health Syst Pharm. 2004;61:1801-1811.
WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [WHO technical report series 843]. Geneva, Switzerland: World Health Organization; 1994.
Teaming up to improve the quality of surgical care
Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43:322-330.
Centers for Medicare and Medicaid Services. www.cms.hhs.gov. Accessed March 17, 2008.
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S-400S.
Specifications Manual Version 2.2. QualityNet. HYPERLINK “http://www.qualitynet.org/dcs/ContentServer?cid=1141662756099&pagename=QnetPublic%2FPage%2FQnetTier2&c=Page” t “_blank” www.qualitynet.org/dcs/ContentServer?cid=1141662756099&pagename=QnetPublic%2FPage%2FQnetTier2&c=Page. Accessed March 17, 2008.
Specifications Manual Version 2.3. QualityNet. HYPERLINK “http://www.qualitynet.org/dcs/ContentServer?cid=1141662756099&pagename=QnetPublic%2FPage%2FQnetTier2&c=Page” t “_blank” www.qualitynet.org/dcs/ContentServer?cid=1141662756099&pagename=QnetPublic%2FPage%2FQnetTier2&c=Page. Accessed March 17, 2008.
Surgical Care Improvement Project. medqic.org/dcs/ContentServer?cid=1089815966976&pagename=Medqic/Content/ParentShellTemplate&parentName=Set ting&c=MQParents. Accessed on March 17, 2008.
Unleash the healing power of pet therapy
Banks MR, Banks WA. The effects of animal-assisted therapy on loneliness in an elderly population in long-term care facilities. J Gerontol A Biol Sci Med Sci. 2002;57(7):M428-M432.
Barker SB, Rogers C, Turner J, Karp A. Suthers-McCabe M. Benefits of interacting with companion animals: a bibliography of articles published in refereed journals during the past 5 years. American Behavioral Scientist. 2003;47(1):94-99.
Centers for Disease Control and Prevention/Healthcare Infection Control Practices Advisory Committee. Guideline for environmental infection control in health-care facilities, 2003. HYPERLINK “http://www.cdc.gov/ncidod/dhqp/gl_environinfection.html” t “_blank” www.cdc.gov/ncidod/dhqp/gl_environinfection.html. Accessed March 7, 2008.
Nimer J, Lundahl B. Animal-assisted therapy: a meta-analysis. Anthrozoos. 2007;20(3):225-238.
Warfarin therapy and pharmacogenomics: A step toward personalized medicine
Consensus Panel on Genetic/Genomic Nursing Competencies. Essential Nursing Competencies and Curricula Guidelines for Genetics and Genomics. Silver Spring, MD: American Nurses Association; 2006. www.genome.gov/17517037. Accessed March 7, 2008.
Department of Health and Human Services. Realizing the Promise of Pharmacogenomics: Opportunities and Challenges. Draft report of the Secretary’s Advisory Committee on Genetics, Health, and Society. www4.od.nih.gov/oba/sacghs/SACGHS_PGx_PCdraft.pdf. Accessed March 7, 2008.
Jenkins J, Calzone K. Genomics to health: establishing the essential nursing competencies for genetics and genomics. J Nurs Scholarsh. 2007;39(1):10-16.
Kage B. Medication reactions send 700,000 Americans a year to emergency rooms. Natural News.com. October 18, 2006. www.newstarget.com/020811.html. Accessed March 7, 2008.
HYPERLINK “http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Mallal%20S%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusDrugs1” Mallal S, HYPERLINK “http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Phillips%20E%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusDrugs1” Phillips E, HYPERLINK “http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Carosi%20G%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlusDrugs1” Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008;7:358(6):568-579.